GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo International PLC (MEX:ENDP) » Definitions » Cyclically Adjusted Price-to-FCF

Endo International (MEX:ENDP) Cyclically Adjusted Price-to-FCF : 0.00 (As of Jun. 24, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Endo International Cyclically Adjusted Price-to-FCF?

As of today (2024-06-24), Endo International's current share price is MXN169.00. Endo International's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was MXN280,540.00. Endo International's Cyclically Adjusted Price-to-FCF for today is 0.00.

The historical rank and industry rank for Endo International's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

During the past years, Endo International's highest Cyclically Adjusted Price-to-FCF was 32.35. The lowest was 0.01. And the median was 3.51.

MEX:ENDP's Cyclically Adjusted Price-to-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 30.14
* Ranked among companies with meaningful Cyclically Adjusted Price-to-FCF only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Endo International's adjusted free cash flow per share data for the three months ended in Dec. 2023 was MXN6.854. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is MXN280,540.00 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Endo International Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Endo International's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo International Cyclically Adjusted Price-to-FCF Chart

Endo International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.12 4.31 2.84 0.08 -

Endo International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.07 0.02 0.01 -

Competitive Comparison of Endo International's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Endo International's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Endo International's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo International's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Endo International's Cyclically Adjusted Price-to-FCF falls into.



Endo International Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Endo International's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=169.00/280540
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endo International's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Endo International's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=6.854/120.7486*120.7486
=6.854

Current CPI (Dec. 2023) = 120.7486.

Endo International Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -27.285 100.573 -32.759
201406 13.476 100.773 16.147
201409 22.630 100.474 27.197
201412 7.638 99.576 9.262
201503 -9.225 99.975 -11.142
201506 -0.771 100.573 -0.926
201509 -9.065 100.274 -10.916
201512 16.964 99.676 20.550
201603 -6.564 99.676 -7.952
201606 47.853 101.072 57.169
201609 -13.525 100.274 -16.287
201612 3.145 99.676 3.810
201703 11.868 100.374 14.277
201706 11.243 100.673 13.485
201709 3.958 100.474 4.757
201712 8.818 100.075 10.640
201803 1.948 100.573 2.339
201806 13.449 101.072 16.067
201809 -3.065 101.371 -3.651
201812 3.538 100.773 4.239
201903 -9.152 101.670 -10.869
201906 14.345 102.168 16.954
201909 0.737 102.268 0.870
201912 -3.096 102.068 -3.663
202003 4.319 102.367 5.095
202006 28.414 101.769 33.713
202009 -9.203 101.072 -10.995
202012 -47.409 101.072 -56.639
202103 19.451 102.367 22.944
202106 10.910 103.364 12.745
202109 3.252 104.859 3.745
202112 -5.968 106.653 -6.757
202203 13.091 109.245 14.469
202206 -19.077 112.779 -20.425
202209 5.252 113.504 5.587
202212 7.205 115.436 7.537
202303 2.361 117.609 2.424
202306 7.659 119.662 7.729
202309 8.138 120.749 8.138
202312 6.854 120.749 6.854

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Endo International  (MEX:ENDP) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Endo International Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Endo International's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Endo International (MEX:ENDP) Business Description

Traded in Other Exchanges
N/A
Address
Simmonscourt Road, Ballsbridge, First Floor, Minerva House, Dublin, IRL, 4
Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.

Endo International (MEX:ENDP) Headlines

No Headlines